INNOBIO FUND
InnoBio is a French venture capital fund of €140 million, managed by CDC Enterprises (www.cdcentreprises.fr) and for 37 per cent subscribed by the FSI and leading international pharmaceutical companies in France. The fund makes direct equity and quasi-equity investments in companies that provide innovative technological products and services in the healthcare market.
INNOBIO FUND
Status:
Active
Similar Organizations
PKO VC
PKO VC is a venture capital fund.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-07-07 | Diotheris | InnoBio Fund investment in Seed Round - Diotheris | N/A |
| 2018-08-09 | Millendo Therapeutics | InnoBio Fund investment in Venture Round - Millendo Therapeutics | 30 M USD |
| 2017-03-20 | Advicenne | InnoBio Fund investment in Venture Round - Advicenne | 16 M EUR |
| 2017-02-24 | TxCell | InnoBio Fund investment in Post-IPO Equity - TxCell | 11 M EUR |
| 2015-01-21 | Sensorion | InnoBio Fund investment in Venture Round - Sensorion | 4 M EUR |
| 2013-11-25 | Pixium Vision | InnoBio Fund investment in Series A - Pixium Vision | 15 M EUR |
| 2013-04-24 | Genticel | InnoBio Fund investment in Series D - Genticel | 18.2 M EUR |
| 2012-12-18 | Poxel | InnoBio Fund investment in Series B - Poxel | 13 M EUR |
| 2012-11-26 | TxCell | InnoBio Fund investment in Series C - TxCell | 12.4 M EUR |
| 2011-01-05 | DBV Technologies | InnoBio Fund investment in Series C - DBV Technologies | 25.5 M USD |